RAONCT07371598
Royal Ancient Oats™ Study
At risk: Primary completion moved 12 months later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
Notable Primary completion pushed from Jun 30, 2026 to Jun 30, 2027 Show 5 more changesShow less
- Eligibility criteria expanded, about 15 words
- Study completion pushed from Sep 15, 2026 to Sep 15, 2027
- Secondary endpoints: details revised at 4 of 5 entries
- Study description revised
- Publications: details revised at 12 of 14 entries
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
To compare the effect of consuming high avenanthramide Royal Ancient Oats™ muffins or conventional oat muffins versus white wheat flour muffins on postprandial glycemic response.
Timeframe: 2 weeks
Secondary (1)
To evaluate the effect of Royal Ancient Oats™ on incretin hormone secretion and satiety hormones.
Arms and interventions
A: Order of receiving muffins differsExperimental
A: Order of receiving muffins differs
B: Order of receiving muffins differsExperimental
B: Order of receiving muffins differs
Dietary supplements: Royal Ancient Oat Flour™
Sites
1 site in 1 country
- Standard Process Nutrition Innovation CenterKannapolis, North Carolina, United States